1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: Visualization of a T1-SP on MR imaging in sinonasal melanomas and nonmelanomatous malignant sinonasal tumors based on consensus readinga
Total Hyperintense Foci on T1WI Present Absent T1-SP (+) T1-SP (−) Sinonasal melanomab 31 23 4 4 Nonmelanomatous malignant tumorb 106 3 19 84 Squamous cell carcinoma 45 2 6 37 Lymphoma 22 1 2 19 Adenoid cystic carcinoma 10 0 4 6 Rhabdomyosarcoma 5 0 0 5 Neuroendocrine carcinoma 4 0 2 2 Adenocarcinoma 4 0 2 2 Malignant fibrous histiocytoma 3 0 1 2 Poorly differentiated carcinoma 3 0 0 3 Spindle cell sarcoma 3 0 0 3 Esthesioneuroblastoma 1 0 0 1 Small round cell sarcoma 1 0 1 0 Inflammatory myofibroblastic sarcoma 1 0 0 1 Malignant peripheral nerve sheath tumor 1 0 0 1 Ewing sarcoma 1 0 1 0 Chondrosarcoma 1 0 0 1 Myoepithelial carcinoma 1 0 0 1